Prediction of recurrence and survival for triple-negative breast cancer (TNBC) by a protein signature in tissue samples

Molecular and Cellular Proteomics

Volumn 14, Issue 11, 2015, Pages 2936-2946

  Campone, Mario ^a,b   Valo, Isabelle ^b   Jézéquel, Pascal ^a   Moreau, Marie ^c   Boissard, Alice ^b   Campion, Loic ^a   Loussouarn, Delphine ^b   Verriele, Véronique ^b   Coqueret, Olivier ^b,c   Guette, Catherine ^b  

^a UMR INSERM U892 CNRS 6299   (France)

^b Team 12   (France)

^c UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPLAKIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE; THROMBOSPONDIN 1; TRYPTOPHAN TRANSFER RNA LIGASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR; ISOCITRATE DEHYDROGENASE 2, HUMAN; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGGRESSIVENESS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; DISTANT METASTASIS; DRUG TARGETING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MICRODISSECTION; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; TRIPLE NEGATIVE BREAST CANCER; TUMOR MICROENVIRONMENT; AGED; CANCER GRADING; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL ANALYSIS; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR RECURRENCE;

ADULT; AGED; BIOMARKERS, TUMOR; DESMOPLAKINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; ISOCITRATE DEHYDROGENASE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; ROC CURVE; SURVIVAL ANALYSIS; TANDEM MASS SPECTROMETRY; THROMBOSPONDIN 1; TRIPLE NEGATIVE BREAST NEOPLASMS; TRYPTOPHAN-TRNA LIGASE;

EID: 84946060455     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M115.048967     Document Type: Article

References (42)

1. Foulkes, W. D., Smith, I. E., and Reis-Filho, J. S. (2010) Triple-negative breast cancer. N. Engl. J. Med. 363, 1938-1948
2. Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., and Bast, R. C., Jr. (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 25, 5287-5312
3. Gámez-Pozo, A., Ferrer, N. I., Ciruelos, E., López-Vacas, R., Martínez, F. G., Espinosa, E., Vara, J. Á. (2013) Shotgun proteomics of archival triplenegative breast cancer samples. Proteomics Clin. Appl. 3-4, 283-291
4. Kim, M. J., Kim, D. H., Jung, W. H., and Koo, J. S. (2014) Expression of metabolism-related proteins in triple-negative breast cancer. Int. J. Clin. Exp. Pathol. 7, 301-12
5. Muñiz Lino, M. A., Palacios-Rodríguez, Y., Rodríguez-Cuevas, S., Bautista-Piña, V., Marchat, L. A., Ruíz-García, E., Astudillo De La Vega, H., González-Santiago, A. E., Flores-Pérez, A., Díaz-Chavez, J., Carlos-Reyes, Á., Álvarez-Sánchez, E., and López-Camarillo, C. (2014) Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9. J. Proteomics. 111, 198-211
6. Liu, N. Q., Stingl, C., Look, M. P., Smid, M., Braakman, RB., De Marchi, T., Sieuwerts, AM., Span, PN., Sweep, F. C., Linderholm, B. K., Mangia, A., Paradiso, A., Dirix, LY., Van Laere, SJ., Luider, TM., Martens, JW., Foekens, JA., Umar, A. (2014) Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer. J. Natl. Cancer Inst. 106, 376
7. Albini, A., and Sporn, M. B. (2007) The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer. 7, 139-147
8. Bizzarri, M., Cucinal, A., and Proietti, S., (2010) The tumor microenvironment as a target for anticancer treatment. Oncobiol. Targets. 1, 3-11
9. Wisńiewski, J. R., Zougman, A., Nagaraj, N., and Mann, M. (2009) Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362
10. Ernoult, E., and Guette, C. (2011) OFFGEL-Isoelectric Focusing Fractionation for the analysis of complex proteome. Neuroproteomics, Edited by Ka Wan Li, Humana Press Inc, Springer protocols U. S. 145-158
11. Shilov, I. V., Seymour, S. L., Patel, A. A., Loboda, A., Tang, W. H., Keating, S. P., Hunter, C. L., Nuwaysir, L. M., and Schaeffer, D. A. (2007) The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 6, 1638-1655
12. Schwacke, J. H., Hill, E. G., Krug, E. L., Comte-Walters, S., and Schey, K. L. (2009) iQuantitator: A tool for protein expression inference using iTRAQ. BMC Bioinformatics 10, 342
13. Grant, J. E., Bradshaw, A. D., Schwacke, J. H., Baicu, C. F., Zile, M. R., and Schey, K. L. (2009) Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus. J. Proteome Res. 8, 4252-4263
14. Besson, D., Pavageau, A. H., Valo, I., Bélanger, A., Eymerit-Morin, C., Moulière A., Chassevent, A., Boisdron-Celle M., Morel A., Solassol J., Campone M., Gamelin E., Barré B., Coqueret O., Guette C. (2011) A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol. Cell. Proteomics 10, M111.009712
15. Zeeberg, B. R., Qin, H., Narasimhan, S., Sunshine, M., Cao, H., Kane, D. W., Reimers, M., Stephens, R. M., Bryant, D., Burt, S. K., Elnekave, E., Hari, D. M., Wynn, T. A., Cunningham-Rundles, C., Stewart, D. M., Nelson, D., and Weinstein, J. N. (2005) High-throughput GoMiner, an "industrialstrength" integrative gene ontology tool for interpretation of multiplemicroarray experiments, with application to studies of common variable immune deficiency (CVID). BMC Bioinformatics 6, 168
16. Eriksson, L., Antti, H., Gottfries, J., Holmes, E., Johansson, E., Lindgren, F., Long, I., Lundstedt, T., Trygg, J., and Wold, S. (2004) Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal. Bioanal. Chem. 380, 419-429
17. Geladi P, and Esbensen K. (1991) Regression on Multivariate Images-Principal Component Regression for Modeling, Prediction and Visual Diagnostic-Tools. J. Chemometr. 5, 97-111
18. Wold, S., Jonsson, J., Sjostrom, M., Sandberg, M., Rännar, S. (1993) DNA and peptide sequences and chemical processes multivariately modeled by principal component analysis and partial least-squares projections to latent structures. Anal. Chim. Acta 277, 239-253
19. Trygg, J., and Wold, S. (2002) Orthogonal projections to latent structures (O-PLS). J. Chemometr. 16, 119-128
20. Allen, E., Yu, Q. C., and Fuchs, E., (1996) Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J. Cell Biol. 133, 1367-1382
21. Wan, H., South, A. P., and Hart, I. R., (2007) Increased keratinocyte proliferation initiated through downregulation of desmoplakin by RNA interference. Exp. Cell Res. 313, 2336-2344
22. Rickelt, S., Winter-Simanowski, S., Noffz, E., Kuhn C., Franke, WW. (2009) Upregulation of plakophilin-2 and its acquisition to adherens junctions identifies a novel molecular ensemble of cell-cell-attachment characteristic for transformed mesenchymal cells. Int. J. Cancer, 125, 2036-2048
23. Leung, C. L., Green, K. J., and Liem, R. K., (2002) Plakins: A family of versatile cytolinker proteins. Trends Cell Biol., 12, 37-45
24. Jonkman, M. F., Pasmooij, A. M., Pasmans, S. G., Van Den Berg, M. P., Ter Horst H. J., Timmer A., Pas H. H., (2005) Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa. Am. J. Hum. Genet. 77, 653-660
25. Kowalczyk, A. P., Bornslaeger, E. A., Borgwardt, J. E., Palka, H. L., Dhaliwal, A. S., Corcoran, C. M., Denning, M. F., and Green, K. J. (1997) The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J. Cell Biol. 139, 773-784
26. Lawler, J. W., Slayter, H. S., and Coligan, J. E. (1978) Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J. Biol. Chem. 253, 8609-8616
27. Iruela-Arispe, M. L., Lombardo, M., Krutzsch, H. C., Lawler, J., and Roberts, D. D. (1999) Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation. 100, 1423-1431
28. Locopo, N., Fanelli, M., and Gasparini, G., (1998) Clinical significance of angiogenic factors in breast cancer. Breast Cancer Res. Treat. 52, 159-173
29. Hyder, S. M., Liang, Y., Wu, J., and Welbern, V. (2009) Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells. Endocr. Relat. Cancer. 16, 809-817
30. Fontana, A., Filleur, S., Guglielmi, J., Frappart, L., Bruno-Bossio, G., Boissier, S., Cabon, F., and Clézardin, P. (2005) Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo. Int. J. Cancer. 116, 686-691
31. McElroy, M. K., Kaushal, S., Tran Cao, H. S., Moossa, A. R., Talamini, M. A., Hoffman, R. M., and Bouvet, M. (2009) Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. Mol. Cancer Ther. 8, 1779-1786
32. Sid, B., Langlois, B., Sartelet, H., Bellon, G., Dedieu, S., and Martiny, L. (2008) Thrombospondin-1 enhances human thyroid carcinoma cell invasion through urokinase activity. Int. J. Biochem. Cell Biol. 40, 1890-1900
33. Trojan, L., Schaaf, A., Steidler, A., Haak, M., Thalmann, G., Knoll, T., Gretz, N., Alken, P., and Michel, M. S. (2005) Identification of metastasisassociated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res. 25, 183-191
34. Horiguchi, H., Yamagata, S., Rong Qian, Z., Kagawa, S., and Sakashita, N. (2013) Thrombospondin-1 is highly expressed in desmoplastic components of invasive ductal carcinoma of the breast and associated with lymph node metastasis. J. Med. Invest. 60, 91-96
35. Kim, S., You, S., and Hwang, D. (2011) Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. Nat. Rev. Cancer 11, 708-718
36. Wakasugi, K., and Schimmel P. (1999) Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284, 147-151
37. Tolstrup, A. B., Bejder, A., Fleckner, J., and Justesen, J. (1995) Transcriptional regulation of the interferon-α-inducible tryptophanyl-tRNA synthetase includes alternative splicing. J. Biol. Chem. 270, 397-403
38. Turpaev, K. T., Zakhariev, V. M., Sokolova, I. V., Narovlyansky, A. N., Amchenkova, A. M., Justesen, J., and Frolova, L. Y. (1996) Alternative processing of the tryptophanyl-tRNA synthetase mRNA from interferontreated human cells. Eur. J. Biochem. 240, 732-737
39. Wakasugi, K., Slike, B. M., Hood, J., Otani, A., Ewalt, K. L., Friedlander, M., Cheresh, D. A., and Schimmel, P. (2002) A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 99, 173-177
40. Kapoor, M., Zhou, Q., Otero, F., Myers, C. A., Bates, A., Belani, R., Liu, J., Luo, J. K., Tzima, E., Zhang, D. E., Yang, X. L., and Schimmel, P. (2008) Evidence for annexin II-S100A10 complex and plasmin in mobilization of cytokine activity of human TrpRS. J. Biol. Chem. 283, 2070-2077
41. Tzima, E., Reader, J. S., Irani-Tehrani, M., Ewalt, K. L., Schwartz, M. A., and Schimmel, P. (2005) VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function. J. Biol. Chem. 280, 2405-2408
42. Ghanipour, A., Jirström, K., Pontén, F., Glimelius, B., Påhlman, L., and Birgisson, H. (2009) The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 18, 2949-2956